Skip to content

Effects of IMT on Pulmonary Functions IN CASES With Inhalation Injury

Effects of Inspiratory Muscle Training on Clinical Predictors of Respiratory Muscle Strength and Lung Function in Burned Patients With Inhalation Injury

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05190497
Enrollment
40
Registered
2022-01-13
Start date
2021-11-30
Completion date
2022-02-28
Last updated
2022-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inhalation Injury, Pulmonary Function, Respiratory Muscle Strength

Keywords

INSPIRATORT TRAINING -INHALATION INJURY

Brief summary

The current study aimed to investigate the effect of inspiratory muscle training (IMT) on pulmonary functions (FEV1and FVC), and respiratory muscle strength in patients with inhalation injury, which may prove to be a promising intervention helping to improve exercise tolerance, relieve dyspnea and suggests an improvement in respiratory muscle function.

Detailed description

Forty male patients suffering from inhalation injury were been included in this study, Participants' ages ranged from 20-35 years old. Patients were selected from the burn department, Om El-Masreen hospital, and randomly assigned into two equal groups. The exercise group received inspiratory muscle training in addition to routine chest physiotherapy in the form of (deep breathing, coughing, and early ambulation) three times per week for four weeks (group A). The Control group received only routine chest physiotherapy (group B). This study obtained ethical approval by the institutional review board of the Faculty of Physical Therapy - Cairo University, with reference number: P.T.REC/012/003431

Interventions

DEVICEExercise group

Maximal respiratory pressure and reflecting muscles strength were measured by a mouth pressure meter

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

The exercise group received inspiratory muscle training in addition to routine chest physiotherapy (group A). The Control group received only routine chest physiotherapy (group B).

Eligibility

Sex/Gender
ALL
Age
20 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Male patients suffering from inhalation injury. * Participant age ranged from 20-35 years old. * All patients had the same medical care. * Participants have received a good explanation of the treatment and measurement device. * Treatment was conducted one month after inhalation injury.

Exclusion criteria

Patients were excluded from this study for any of the following cases such as * Instability of patient's medical condition. * Presence of any diseases that could affect the study results. * Participants having respiratory, cardiac, or neurological diseases that affect pulmonary functions.

Design outcomes

Primary

MeasureTime frameDescription
PULMONARY FUNCTION TEST3 MONTHSEach patient's weight in kilograms, and height in meters were recorded and entered the machine. An individual sat in a chair and inhaled deeply before closing their mouth tightly around the tube. Several exercises were carried out until the patient comprehended and was comfortable with the instruction. The patient inhaled deeply and exhaled as quickly as possible into the spirometer(Morgan Trans Flow Test Vicatest p2 (Kent, ME 87 ED, England).
Respiratory muscles Strength Measurement3 MONTHSMaximal respiratory pressure and reflecting muscles strength were measured by a mouth pressure meter (Pony FX; COSMED, Rome, Italy) in the sitting position. The highest maximal expiratory pressure (MEP) in cmH2O, and maximal inspiratory pressure (MIP) in cmH2O values in three or more attempts were chosen. Investigators calculated the predicted MEP and MIP values based on age, height, and weight

Countries

Egypt

Contacts

Primary ContactKHALED T AHMED, Asso Prof
khaled.takey@must.edu.eg00201115586016
Backup ContactAssma F attallah, Ass Prof
Zayedsameh40@yahoo.com00201117744974

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026